ENZYME

Details for Australian Patent Application No. 2002228224 (hide)

Owner OXFORD BIOMEDICA (UK) LIMITED

Inventors GRIMSHAW, Matthew; BALKWILL, Frances

Pub. Number AU-A-2002228224

PCT Pub. Number WO2002/062979

Priority 0102946.1 06.02.01 GB

Filing date 5 February 2002

Wipo publication date 19 August 2002

International Classifications

C12N 009/16 Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

A61P 035/00 Antineoplastic agents

C12N 015/55 Mutation or genetic engineering - Hydrolases (3)

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 015/86 Mutation or genetic engineering - Viral vectors

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002228224

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228225-INSERTIONAL MUTAGENESIS TECHNIQUE

2002228223-Flow field plate geometries